ABSTRACT
ETHNOPHARMACOLOGICAL RELEVANCE: The plant, Ficus religiosa (L.) from the family Moraceae, has been extensively used in Ayurveda and Unani. Traditionally this plant is known for the treatment of constipation, liver diseases and neurological disorders that are related to hypothyroidism. AIM OF THE STUDY: This study was primarily designed to evaluate the effect of Ficus religiosa leaf (FL) extract in ameliorating hypothyroidism in rats and to identify the major bioactive compounds in the test extract that might be responsible for the thyroid-altering activity. In addition, the probable mechanism underlying the thyroid regulation of the main FL constituents were analyzed by molecular docking. MATERIALS AND METHODS: Adult female Wistar rats were used. LC-ESI-MS/MS was performed to identify the compounds present in the extract. HPLC analysis of FL extract was also performed. A pilot study was made using 3 doses of FL extract. Out of 50, 100, and 200 mg/kg, 100 mg/kg appeared to be the most effective one as it could increase thyroid hormones and decreased TSH levels. In the final experiment, propyl-thiouracil (PTU)-induced hypothyroid rats were orally treated with FL extract (100 mg/kg) or L-thyroxine (100 µg/kg, i.p.) daily for 28 consecutive days. On 29th day, all rats were sacrificed and the serum levels of triiodothyronine (T3), thyroxine (T4), thyrotropin (TSH), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and hepatic 5' deiodinase-1(5'D1) were estimated by ELISA. Liver marker enzymes (alanine aminotransferase, ALT and aspartate aminotransferase, AST); total cholesterol (TC) and triglycerides (TG); hepatic lipid peroxidation (LPO) and the activities of antioxidants such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione (GSH) content were estimated in liver tissues. RESULTS: LC-MS-MS analyses of the leaf extract identified 11 compounds including the three major compounds, betulinic acid (BA), chlorogenic acid (CGA), and quinic acid (QA). While the PTU treatment decreased the levels of thyroid hormones and 5'D1 activity, it increased the TSH, ALT, AST, TNF-α, IL-6, TC, and TG levels. Furthermore, hepatic LPO significantly increased with a decrease in reduced GSH, SOD, CAT, and GPx. However, FL treatment in PTU-induced animals nearly reversed these adverse effects and improved liver function by decreasing ALT, AST, hepatic LPO and increasing the levels of antioxidants. FL not only improved the liver histology, but also suppressed the inflammatory cytokines, TNF-α and IL-6 in PTU-induced animals. A molecular docking study towards the understanding of the thyroid stimulatory mechanism of action revealed that BA, CGA, and QA might have augmented thyroid hormones by interacting with the thyroid hormone receptor (TRß1) and TSH receptor (TSHR). CONCLUSION: For the first time, we report the pro-thyroidal potential of Ficus religiosa leaf extract. We postulate that its main bioactive compounds, BA, CGA, and QA involved in this action may serve as novel thyroid agonists in ameliorating hypothyroidism.
Subject(s)
Ficus , Hypothyroidism , Rats , Animals , Rats, Wistar , Polyphenols/pharmacology , Tumor Necrosis Factor-alpha/pharmacology , Tandem Mass Spectrometry , Interleukin-6 , Molecular Docking Simulation , Pilot Projects , Hypothyroidism/chemically induced , Hypothyroidism/drug therapy , Antioxidants/pharmacology , Antioxidants/therapeutic use , Antioxidants/chemistry , Thyroid Hormones , Thyroxine , Liver , Thyrotropin/pharmacology , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Plant Extracts/chemistry , Propylthiouracil/toxicity , Phytochemicals/pharmacology , Phytochemicals/therapeutic use , Superoxide DismutaseABSTRACT
BACKGROUND: Diabetes mellitus (DM) is a well-known global metabolic disorder. For its treatment, glibenclamide (GLB) is very often prescribed. However, herbal drugs are considered effective and better alternatives due to their low risk of side effects. This study was conducted to determine the combined effects of GLB and Pterocarpus marsupium (PM, a commonly available Indian herb) extract for the effective and safe treatment of hyperglycemia in the mouse model. METHODS: Healthy adult male mice were distributed into five groups (n=7 in each group). Group I acted as the control, whereas groups II, III, IV, and V were considered experimental groups which received a single dosage (150 mg/kg body weight) of alloxan (ALX) intraperitoneally (i.p.). In addition, groups III, IV, and V received a pre-standardized dose of GLB (500 µg/kg body weight), PM extract (150 mg/kg body weight), and GLB+PM, respectively, at the same doses as used in individual treatment, after the seventh day of ALX administration for 15 days and the alterations in different DM related parameters were evaluated. RESULTS: ALX-induced hyperglycemia and other adverse effects were nearly normalized by GLB and PM co-treatment as evidenced by marked suppression in glucose, triglyceride, total-cholesterol, lipid-peroxidation, and lipid-hydroperoxides with an increase in antioxidants status and liver glycogen content. The positive effects were more pronounced when both GLB and PM were given, as compared to that of either of the drugs, administered alone. Liver ultra-structure, analyzed through histology and transmission electron microscopy revealed normalization of the ALX-induced damaged hepatocytes. The presence of epicatechin, the major phytoconstituent of the PM extract, as confirmed by high-performance liquid chromatography (HPLC), is responsible for its antioxidative and glucose-lowering activities. CONCLUSION: These findings reveal that PM, along with GLB, exhibits synergistic and better effects than the individual drug in regulating hyperglycemia and associated changes in alloxan-induced mice.
Subject(s)
Diabetes Mellitus, Experimental , Hyperglycemia , Male , Mice , Animals , Plant Extracts/chemistry , Phytotherapy , Glyburide/adverse effects , Alloxan/adverse effects , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/drug therapy , Antioxidants/pharmacology , Antioxidants/therapeutic use , Hyperglycemia/drug therapy , Lipids , Glucose , Body Weight , Hypoglycemic Agents/pharmacology , Hypoglycemic Agents/therapeutic use , Blood GlucoseABSTRACT
Untreated hyperthyroidism may develop serious complications. This attempt was made to investigate the potential of Aloe vera gel in regulating experimentally induced hyperthyroidism in rats. Female Wistar rats were made hyperthyroid with L-thyroxine (L-T4) at 0.5 mg/kg/day, i.p. for 14 days and the effects of Aloe vera methanolic fraction (AVMF) (50 or 500 mg/kg/day, p.o.,) and a conventional antithyroid drug propylthiouracil (PTU) (10 mg/kg, i.p.) for 30 days were studied in those hyperthyroid rats. At the end, alterations in serum thyroid hormones and thyroid stimulating hormone (TSH); hepatic 5'mono-deiodinase-1(5'D1) activity, oxidative stress markers and antioxidants; serum inflammatory cytokines and the expression of thyrotropin receptor in thyroid gland were evaluated in all experimental animals. Hyperthyroid condition was confirmed by an increase in thyroid hormone levels and hepatic 5'D-1 activity with a decrease in TSH. However, either AVMF or PTU treatment in hyperthyroid rats decreased the levels of thyroid hormones and 5'D1 activity. AVMF administration in T4-induced rats also decreased the oxidative stress markers such as thiobarbituric acid reactive substances and lipid hydroperoxides and increased the antioxidant levels in liver tissues. Levels of liver marker enzymes, cytokines and different lipids were decreased in T4-induced AVMF treated rats. Further, a down regulation in the TSHR expression in thyroid was observed in AVMF or PTU treated groups. All these thyroid inhibiting effects were supported by an improvement in thyroid histology in hyperthyroid rats. It appears, about 15 compounds, as evidenced by LC-MS/MS study, mostly phenolics are involved in this anti-thyroid effects of the test compound.
Subject(s)
Aloe/metabolism , Hyperthyroidism/drug therapy , Receptors, Thyrotropin/drug effects , Animals , Chromatography, Liquid/methods , Female , Inflammation/drug therapy , Inflammation/metabolism , Liver/metabolism , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Propylthiouracil/pharmacology , Rats , Rats, Wistar , Receptors, Thyrotropin/metabolism , Tandem Mass Spectrometry/methods , Thyroid Gland/drug effects , Thyroid Gland/metabolism , Thyroid Hormones/metabolism , Thyrotropin/blood , Thyrotropin/pharmacology , Thyroxine/adverse effectsABSTRACT
Thyrotoxicosis is a clinical syndrome that commonly results from excess secretion and/or release of thyroid hormones in the circulation. It affects most of the body systems and if not treated properly may lead to serious health problems. In this investigation, we isolated a phenolic compound, chavibetol (CHV) from Piper betel leaf and evaluated its possible ameliorative effects in thyrotoxicosis of rats. Adult female rats were rendered thyrotoxic by the administration of L-thyroxine (L-T4) at 500 µg/kg/day, i.p., for 12 days, and then chavibetol (20.0 mg/kg, p.o.) was administered for 2 weeks. L-T4 administration elevated the concentration of serum thyroxine and triiodothyronine, activities of alanineaminotransferase and aspartate aminotransferase, and decreased the thyrotropin level as well as the expression of thyroid peroxidase (TPO). Further, it increased the activities of hepatic 5'mono-deiodinase-I, glucose-6--phosphatase, sodium-potasium-ATPase, and lipid peroxidation, and depleted the cellular antioxidants. However, chavibetol treatment to thyrotoxic rats normalized almost all these indices including TPO and also preserved the integrity of thyroid tissues suggesting its potential to correct thyrotoxicosis. Effects of CHV were more or less similar to a conventional antithyroid drug, propylthiouracil (PTU).
Subject(s)
Antithyroid Agents/therapeutic use , Eugenol/analogs & derivatives , Iodide Peroxidase/metabolism , Thyrotoxicosis/drug therapy , Animals , Antithyroid Agents/pharmacology , Eugenol/pharmacology , Eugenol/therapeutic use , Female , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/metabolism , Piper , Plant Leaves , Rats, Wistar , Thyroid Gland/drug effects , Thyroid Gland/metabolism , Thyroid Gland/pathology , Thyrotoxicosis/blood , Thyrotoxicosis/metabolism , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/bloodABSTRACT
The hitherto unknown role of saponin in the regulation of thyrotoxicosis has been revealed in chemically-induced thyrotoxic rats. l-T4 (l-thyroxine) administration at pre-standardized dose of 500-µg/kg body weight for 12days increased the levels of thyroid hormones, enhanced the activity of hepatic 5'-monodeiodinase I (5'DI) and glucose-6-phosphatase (G-6Pase) as well as lipid peroxidation (LPO) with a parallel decrease in the levels of antioxidative enzymes. However, administration of the isolated saponin for 15days ameliorated the T4-induced alterations in serum thyroid hormones, hepatic LPO, G-6-Pase and 5'DI activity, and improved the cellular antioxidant status, indicating its antithyroidal and antioxidative potential. These effects of the test compound were comparable to a reference antithyroid drug, Propylthiouracil (PTU), suggesting that the test saponin may act as a potent anti-thyroid agent.
Subject(s)
Antithyroid Agents/therapeutic use , Malvaceae/chemistry , Plant Leaves/chemistry , Spirostans/therapeutic use , Thyrotoxicosis/drug therapy , Animals , Antithyroid Agents/chemistry , Antithyroid Agents/isolation & purification , Female , Rats , Spirostans/chemistry , Spirostans/isolation & purificationABSTRACT
In the present study we have evaluated the antioxidant activities of different fractions (hexane, ethyl acetate, n-butanol and aqueous fractions) of Prunus persica fruit. For extraction simple warring blender method was employed and total phenolic and flavonoid contents were correlated with different antioxidant activities (total antioxidant, 2,2-diphenyl-1-picrylhydrazyl (DPPH), H2O2 scavenging, superoxide radical scavenging, iron chelating and their reducing power properties). Different in vitro antioxidant studies showed that ethyl acetate and n-butanol fractions had the maximum activities that were well correlated with total phenolic and flavonoid contents. Maximum yield (25.14±2.2%) was obtained in its aqueous fraction. Both ethyl acetate and n-butanol fractions showed significant inhibitory effects on different antioxidant activities. A significantly high correlation coefficient existed between total antioxidant activities and with total phenolic as well as total flavonoid contents. It appears that ethyl acetate and n-butanol fractions of P. persica may serve as new potential sources of natural antioxidants and could be of therapeutic use in treating several diseases.
Subject(s)
Antioxidants/analysis , Fruit/chemistry , Prunus/chemistry , Biphenyl Compounds/chemistry , Chemical Fractionation , Flavonoids/analysis , Free Radical Scavengers/chemistry , Inhibitory Concentration 50 , Iron Chelating Agents/chemistry , Oxidation-Reduction , Phenols/analysis , Picrates/chemistry , Plant Extracts/chemistryABSTRACT
OBJECTIVE: Protective effects of trigonelline (TRG) isolated from fenugreek seed were evaluated in isoproterenol (ISO)-induced myocardial dysfunctions in adult rats and a proteomic approach was applied to understand its mechanism of action. METHODS: In a preliminary experiment, effects of TRG at 20, 40, and 80 mg/kg for 20 d were studied in ISO-induced (100 mg/kg) adult rats. As 40 mg/kg was found the most effective concentration, in the final experiment, effects of 40 mg/kg of the test drug were investigated using different indices including cardiac marker enzymes, lipid peroxidation, antioxidants, cardiac histology, and electrocardiogram. Proteomic analyses were also done in cardiac myocytes. RESULTS: ISO administration increased serum levels of cardiac markers (creatine kinase-MB, glutamate pyruvate transaminase, and lactate dehydrogenase) and exhibited a positive reaction in the TROP-T test. It also increased the cardiac lipid peroxidation and decreased the cellular antioxidants. Proteomic data revealed nine protein spots, seven were down-regulated and two up-regulated. The overexpressions of two small stress proteins, heat shock protein (Hsp)27 and αB crystallin were confirmed by Western blot analysis. All these alterations were restored to nearly normal values in 40 mg/kg of TRG-pretreated animals, suggesting its cardioprotective effects, which were further confirmed by histologic examinations and triphenyl tetrazolium chloride staining assay. CONCLUSION: For the first time, our study revealed the down-regulation of Hsp27 and αB-crystallin and (CaMKII delta) isoform by TRG. As the test compound prevented the ISO-induced myocardial injury, its therapeutic use may further be explored.
Subject(s)
Alkaloids/pharmacology , HSP27 Heat-Shock Proteins/metabolism , Isoproterenol/toxicity , Myocardial Infarction/prevention & control , Plant Extracts/chemistry , Trigonella/chemistry , alpha-Crystallin B Chain/metabolism , Alanine Transaminase/blood , Animals , Antioxidants/pharmacology , Aspartate Aminotransferases/blood , Cardiotonic Agents/pharmacology , Creatine Kinase, MB Form/blood , Down-Regulation , HSP27 Heat-Shock Proteins/genetics , L-Lactate Dehydrogenase/blood , Lipid Peroxidation/drug effects , Myocardial Infarction/blood , Myocardial Infarction/chemically induced , Proteomics , Rats , Rats, Wistar , alpha-Crystallin B Chain/geneticsABSTRACT
Hitherto unknown protective effect of N,α-L-rhamnopyranosyl vincosamide (VR), isolated from Moringa oleifera leaves in isoproterenol (ISO)-induced cardiac toxicity was evaluated in rats. Oral administration of VR at 40 mg/kg for 7 days markedly reduced the ISO-induced increase in the levels of serum cardiac markers such as troponin-T, creatine kinase-MB, lactate dehydrogenase and glutamate pyruvate transaminase as well as cardiac lipid peroxidation with a parallel increase in the cellular antioxidants suggesting its cardio-protective and free radical scavenging potential, which was latter confirmed by in vitro study. Rats treated with test compound also improved the ISO-induced abnormal changes in ECG as well as in cardiac histology. A reduction in myocardial necrosis was further evidenced by the tri-phenyl tetrazolium chloride (TTC) stain in isolated test drug pretreated rats. These findings suggest the cardio-protective potential of the isolated alkaloid and possibly the beneficial action is mediated through its free radical scavenging property.
Subject(s)
Cardiotonic Agents/pharmacology , Heart Diseases/prevention & control , Indole Alkaloids/pharmacology , Moringa oleifera/chemistry , Animals , Cardiotonic Agents/chemistry , Cardiotonic Agents/isolation & purification , Cardiotoxins , Free Radical Scavengers/chemistry , Free Radical Scavengers/isolation & purification , Free Radical Scavengers/pharmacology , Heart Diseases/chemically induced , Indole Alkaloids/chemistry , Indole Alkaloids/isolation & purification , Isoproterenol , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Leaves/chemistry , Rats , Rats, WistarABSTRACT
The hitherto unknown glucose regulating role of three vegetable peels from cucurbitaceae family was evaluated. In a preliminary study, effects of ethanolic extracts of Cucurbita pepo, Cucumis sativus and Praecitrullus fistulosus peels were studied at 250 and 500 mg kg(-1) d(-1) for 15 days in the alterations in serum glucose and in hepatic lipid peroxidation (LPO) in male mice. In the pilot experiment, the effective and safe concentration of each peel was administered (p.o.) for 10 consecutive days and then on 11th and 12th days alloxan was administered along with peel extracts. The treatment was continued up to 15th day. At the end, alterations in serum glucose, insulin, triiodothyronine, thyroxine, total cholesterol, triglyceride, high density lipoprotein, low density lipoprotein, very low density lipoprotein, hepatic lipid peroxidation, superoxide dismutase and catalase were studied. All the three peel extracts nearly reversed most of these changes induced by alloxan suggesting their possible role in ameliorating diabetes mellitus and related changes in serum lipids. However, Cucurbita pepo peel was found to be the most effective. Total polyphenols, flavonoids and ascorbic acid contents of the test peels were also estimated, which appear to be associated with the observed antidiabetic and antioxidative potentials.
Subject(s)
Blood Glucose/metabolism , Cucurbitaceae/chemistry , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/therapeutic use , Lipids/blood , Phytotherapy , Plant Extracts/therapeutic use , Animals , Ascorbic Acid/analysis , Ascorbic Acid/pharmacology , Ascorbic Acid/therapeutic use , Catalase/blood , Flavonoids/analysis , Flavonoids/pharmacology , Flavonoids/therapeutic use , Fruit , Hypoglycemic Agents/analysis , Hypoglycemic Agents/pharmacology , Insulin/blood , Lipid Peroxidation , Liver/metabolism , Male , Mice , Phenols/analysis , Phenols/pharmacology , Phenols/therapeutic use , Plant Extracts/chemistry , Plant Extracts/pharmacology , Polyphenols , Superoxide Dismutase/blood , Thyroxine/blood , Triiodothyronine/blood , Vegetables , Vitamins/analysis , Vitamins/pharmacology , Vitamins/therapeutic useABSTRACT
An investigation was carried out to reveal the possible ameliorative role of two plant extracts on an antidiabetic drug-induced hypothyroidism in Type 2 diabetic animals. Dexamethasone (1.0 mg/kg, i.m.) administration caused hyperglycemia with a parallel increase in renal lipid peroxidation (LPO), relative risk ratio (RR), and the concentrations of serum insulin; total cholesterol (TC); low-density lipoprotein cholesterol (LDL-C); very low-density lipoprotein cholesterol (VLDL-C) and triglycerides (TG). It decreased serum triiodothyronine (T3), thyroxine (T4) and high-density lipoprotein cholesterol (HDL-C) levels as well as renal superoxide dismutase (SOD); catalase (CAT) and reduced glutathione (GSH) content. Administration with metformin (150 mg/kg, orally) to diabetic animals further reduced circulating T4 level and caused severe hypothyroidism. It also reduced renal LPO, RR, serum concentrations of insulin; glucose and LDL-C with a parallel increase in cellular antioxidants. While oral administration with either Withania somnifera (1.4 g/kg) or Bauhinia purpurea (2.5 mg/kg) extract along with dexamethasone and metformin elevated the concentrations of circulating T3 and T4 to euthyroid level. The plant extracts also corrected RR ratio and serum concentration of lipids. The findings of the present study, for the first time, reveal that the evaluated plant extracts have a potential to ameliorate metformin-induced hypothyroidism in Type 2 diabetic subjects.
Subject(s)
Bauhinia/chemistry , Hypothyroidism/drug therapy , Plant Extracts/therapeutic use , Withania/chemistry , Animals , Dexamethasone , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Female , Hypothyroidism/chemically induced , Metformin , Mice , Plant Bark/chemistry , Plant Roots/chemistry , Thyroxine/blood , Triiodothyronine/bloodABSTRACT
The modulatory influence of the phytoestrogen biochanin A, an isoflavinoid found in red clover (Trifolium pratense), on the differentiation and proliferation of mammary epithelial cells and the expression of estrogen receptor-alpha (ER-alpha) in female prepubertal Sprague-Dawley rat mammary glands was examined, for which there have been no reports to date. Biochanin A (500 microg/g bw) was injected subcutaneously on days 16, 18 and 20 post-partum. The mammary gland was dissected out and terminal end buds, terminal ducts and lobules were counted. ER-alpha, Bcl2, Bax and caspase-3 expression were determined by immunohistochemistry. Estradiol benzoate (EB) (500 ng/g bw) and dimethyl sulphoxide (DMSO) were used as the reference and vehicle, respectively. The results showed a significant enhancement of differentiation at post-natal day (PND) 21 as well as at PND 50 in the mammary glands. There was a significant decrease of ER-alpha expression at PND 21 and an increased expression of the same at PND 50, whereas increased proliferation at PND 21 and increased apoptosis at PND 50 in the mammary glands were observed in biochanin A treated animals. The mode and magnitude of the effect of biochanin A was almost similar to that of EB. These findings suggested that prepubertal exposure to biochanin A modulated the regulatory processes and in turn enhanced the differentiation and development of mammary glands in female rats. These observations may have significance in human health.
Subject(s)
Cell Differentiation/drug effects , Estrogen Receptor alpha/metabolism , Genistein/pharmacology , Mammary Glands, Animal/drug effects , Phytoestrogens/pharmacology , Animals , Apoptosis/drug effects , Caspase 3/metabolism , Estradiol/analogs & derivatives , Estradiol/pharmacology , Female , Mammary Glands, Animal/cytology , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Rats, Sprague-Dawley , bcl-2-Associated X Protein/metabolismABSTRACT
An investigation was made to evaluate the pharmacological importance of fruit peel extracts of Mangifera indica (MI), Citrullus vulgaris (CV) and Cucumis melo (CM) with respect to the possible regulation of tissue lipid peroxidation (LPO), thyroid dysfunctions, lipid and glucose metabolism. Pre-standardized doses (200mg/kg of MI and 100mg/kg both of CV and CM), based on the maximum inhibition in hepatic LPO, were administered to Wistar albino male rats for 10 consecutive days and the changes in tissue (heart, liver and kidney) LPO and in the concentrations of serum triiodothyronine (T(3)), thyroxin (T(4)), insulin, glucose, alpha-amylase and different lipids were examined. Administration of three test peel extracts significantly increased both the thyroid hormones (T(3) and T(4)) with a concomitant decrease in tissue LPO, suggesting their thyroid stimulatory and antiperoxidative role. This thyroid stimulatory nature was also exhibited in propylthiouracil (PTU) induced hypothyroid animals. However, only minor influence was observed in serum lipid profile in which CM reduced the concentrations of total cholesterol and low-density lipoprotein-cholesterol (LDL-C), while CV decreased triglycerides and very low-density lipoprotein-cholesterol (VLDL-C). When the combined effects of either two (MI+CV) or three (MI+CV+CM) peel extracts were evaluated in euthyroid animals, serum T(3) concentration was increased in response to MI+CV and MI+CV+CM treatments, while T(4) level was elevated by the combinations of first two peels only. Interestingly, both the categories of combinations increased T(4) levels, but not T(3) in PTU treated hypothyroid animals. Moreover, a parallel increase in hepatic and renal LPO was observed in these animals, suggesting their unsafe nature in combination. In conclusion the three test peel extracts appear to be stimulatory to thyroid functions and inhibitory to tissue LPO but only when treated individually.
Subject(s)
Citrullus/chemistry , Cucumis melo/chemistry , Hypothyroidism/prevention & control , Mangifera/chemistry , Plant Extracts/pharmacology , Animals , Antithyroid Agents/toxicity , Hypothyroidism/blood , Hypothyroidism/chemically induced , Lipid Peroxidation/drug effects , Male , Propylthiouracil/toxicity , Rats , Rats, WistarABSTRACT
Peel extracts from Citrus sinensis, Punica granatum, and Musa paradisiaca were investigated for their effects on tissue lipid peroxidation (LPO) and on the concentration of thyroid hormones, insulin, and glucose in male rats. In vitro inhibition of H(2)O(2)-induced LPO in red blood cells of rats by 0.25, 0.50, 1.0, and 2.0 microg/mL C. sinensis, P. granatum, and M. paradisiaca peel extracts was observed in a dose-specific manner. Maximum inhibition was observed at 0.50 microg/mL C. sinensis, 2.0 microg/mL P. granatum, and 1.0 microg/mL M. paradisiaca. In the in vivo investigation, out of four different concentrations of each peel extract, 25, 200, and 100 mg/kg C. sinensis, P. granatum, and M. paradisiaca, respectively, were found to maximally inhibit hepatic LPO. The most effective doses were further evaluated for effects on serum triiodothyronine (T(3)), thyroxine (T(4)), insulin, and glucose concentrations. C. sinensis exhibited antithyroidal, hypoglycemic, and insulin stimulatory activities, in addition to inhibition of LPO, as it significantly decreased the serum T(4) (P < .05) and glucose (P < .001) concentrations with a concomitant increase in insulin levels (P < .05). P. granatum decreased LPO in hepatic, cardiac, and renal tissues (P < .01, P < .001, and P < .05, respectively) and serum glucose concentration (P < .01). M. paradisiaca strongly inhibited the serum level of thyroid hormones (P < .01 for both T(3) and T(4)) but increased the level of glucose (P < .05). These findings reveal the hitherto unknown potential of the tested peel extracts in the regulation of thyroid function and glucose metabolism. Besides antiperoxidative activity, C. sinensis extract has antithyroidal, hypoglycemic, and insulin stimulatory properties, which suggest its potential to ameliorate both hyperthyroidism and diabetes mellitus.
Subject(s)
Blood Glucose/metabolism , Citrus sinensis/chemistry , Lythraceae/chemistry , Musa/chemistry , Plant Extracts/administration & dosage , Thyroid Hormones/blood , Animals , Erythrocytes/chemistry , Erythrocytes/drug effects , Fruit/chemistry , Hydrogen Peroxide/pharmacology , Insulin/blood , Lipid Peroxidation/drug effects , Male , Phytotherapy , Rats , Rats, Wistar , Thyroxine/blood , Triiodothyronine/bloodABSTRACT
Although chemopreventive action of Biochanin A against various cancers including that of prostate, breast, colon, and fore-stomach has been reported earlier, none of the studies was made in prepubertal subjects. The present study appears to be the first one on prepubertal rats that indicates the efficacy of the test compound in the prevention of tumorigenesis. The antioxidative status and xenobiotic metabolism were also evaluated to understand the mechanism of Biochanin A induced prevention of cancer. For the tumorigenesis study 500 microg/g bwt of Biochanin A or vehicle dimethyl sulfoxide (DMSO) s.c, was injected at 16th, 18th, and 20th days post-partum followed by the administration of dimethylbenz[a]nthracene (DMBA) (80 microg/g bwt) at 50th day. In another set of experiments, to study the involvement of peroxidative process in the mechanism of action of test compound, different antioxidant parameters were studied following the administration of two different doses of Biochanin A (0.5 and 50 mg/kg bwt, through oral gavage for 10 days) in the prepubertal rats from day 16 post-partum. Results showed a significant reduction in the mammary tumors (more than 40%) in Biochanin A treated animals, as compared to animals treated with DMBA only. Spectrophotometric enzyme estimations revealed that the specific activities of antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione transferase (GST), DT-diaphorase (DTD), and reduced glutathione (GSH) levels were increased, whereas specific activities of lactate dehydrogenase (LDH) and lipid peroxidation (LPO) were decreased significantly, both in liver as well as in mammary gland, in animals treated with Biochanin A prepubertally. These results reveal the possible involvement of the antioxidative and metabolic enzymes in the suppression of cancer burden and incidence in a prepubertal rat model suggesting that the intake of this phytoestrogen at an early stage may help in lowering the risk of mammary tumor.
Subject(s)
Antioxidants/metabolism , Genistein/therapeutic use , Lipid Peroxidation/drug effects , Mammary Neoplasms, Animal/prevention & control , Sexual Maturation , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Antineoplastic Agents, Phytogenic/therapeutic use , Drug Evaluation, Preclinical , Enzyme Activation/drug effects , Female , Genistein/pharmacology , L-Lactate Dehydrogenase/metabolism , Liver/drug effects , Liver/enzymology , Mammary Glands, Animal/drug effects , Mammary Glands, Animal/enzymology , Mammary Neoplasms, Animal/enzymology , Mammary Neoplasms, Animal/metabolism , Mammary Neoplasms, Animal/pathology , Oxidative Stress/drug effects , Rats , Rats, Sprague-Dawley , Sexual Maturation/drug effects , Tumor Burden/drug effectsABSTRACT
Hitherto unknown efficacy of the peel extracts of Mangifera indica (MI), Cucumis melo (CM) and Citrullus vulgaris (CV) fruits in ameliorating the diet-induced alterations in dyslipidemia, thyroid dysfunction and diabetes mellitus have been investigated in rats. In one study, out of 4 different doses (50-300 mg/kg), 200 mg/kg of MI and 100 mg/kg for other two peel extracts could inhibit lipidperoxidation (LPO) maximally in liver. In the second experiment rats were maintained on pre-standardized atherogenic diet CCT (supplemented with 4% cholesterol, 1% cholic acid and 0.5% 2-thiouracil) to induce dyslipidemia, hypothyroidism and diabetes mellitus and the effects of the test peel extracts (200 mg/kg of MI and 100 mg/kg for CM and CV for 10 consecutive days) were studied by examining the changes in tissue LPO (in heart, liver and kidney), concentrations of serum lipids, thyroid hormones, insulin and glucose. Rats, treated simultaneously with either of the peel extracts reversed the CCT-diet induced increase in the levels of tissue LPO, serum lipids, glucose, creatinine kinase-MB and decrease in the levels of thyroid hormones and insulin indicating their potential to ameliorate the diet induced alterations in serum lipids, thyroid dysfunctions and hyperglycemia/diabetes mellitus. A phytochemical analysis indicated the presence of a high amount of polyphenols and ascorbic acid in the test peel extracts suggesting that the beneficial effects could be the result of the rich content of polyphenols and ascorbic acid in the studied peels.
Subject(s)
Citrullus/chemistry , Cucumis melo/chemistry , Dyslipidemias/drug therapy , Hyperglycemia/drug therapy , Hypothyroidism/drug therapy , Mangifera/chemistry , Phytotherapy , Plant Extracts/therapeutic use , Animals , Ascorbic Acid/analysis , Atherosclerosis/blood , Blood Glucose/metabolism , Creatine Kinase, MB Form/blood , Diabetes Mellitus/drug therapy , Diet, Atherogenic , Flavonoids/analysis , Fruit/chemistry , Hypoglycemic Agents/therapeutic use , Lipid Peroxidation/drug effects , Lipids/blood , Phenols/analysis , Polyphenols , Rats , Rats, Wistar , Thyroxine/blood , Triiodothyronine/bloodABSTRACT
An investigation on the effects of four different concentrations of peel extract from Citrus sinensis (CS) or Punica granatum (PG) in male mice revealed the maximum glucose lowering and antiperoxidative activities at 25 mg/kg of CS and 200 mg/kg of PG. In a separate experiment their potential was evaluated with respect to the regulation of alloxan induced diabetes mellitus. While a single dose of alloxan (120 mg/kg) increased the serum levels of glucose and alpha-amylase activity, rate of water consumption and lipid peroxidation (LPO) in hepatic, cardiac and renal tissues with a parallel decrease in serum insulin level, administration of 25 mg/kg of CS or 200 mg/kg of PG was found to normalize all the adverse changes induced by alloxan, revealing the antidiabetic and anti peroxidative potential of test fruit peel extracts. Subsequent phytochemical analysis indicated that the high content of total polyphenols in the test peels might be related to the antidiabetic and antiperoxidative effects of the test peels.
Subject(s)
Citrus , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/therapeutic use , Lythraceae , Plant Extracts/therapeutic use , Animals , Fruit/chemistry , Male , MiceABSTRACT
Present investigation was made to reveal the involvement of a quercetin in the antidiabetic and antiperoxidative effects of Annona squamosa leaf extract. Quercetin-3-O-glucoside (characterized by UV, IR, MS and NMR analyses) was isolated from Annona squamosa leaves and examined for its potential to regulate alloxan-induced hyperglycemia and lipid peroxidation (LPO) in rats. While in alloxan treated animals, an increase in the concentration of serum glucose with a parallel decrease in insulin level was observed, administration of 15 mg/kg/day of isolated quercetin-3-O-glucoside for 10 consecutive days to the hyperglycemic animals reversed these effects and simultaneously inhibited the activity of hepatic glucose-6-phosphatase. It further decreased the hepatic and renal LPO with a concomitant increase in the activities of antioxidative enzymes, such as catalase (CAT) and superoxide dismutase (SOD) and in glutathione (GSH) content, indicating its safe and antiperoxidative effects. These findings suggest the potential of quercetin-3-O-glucoside in the amelioration of diabetes mellitus and tissue lipid peroxidation. It also appears that the antidiabetic effects of A. squamosa leaf extract is possibly mediated through the insulin stimulating and/or free radical scavenging properties of its active constituent, quercetin-3-O-glucoside.
Subject(s)
Annona/chemistry , Antioxidants/pharmacology , Hypoglycemic Agents/pharmacology , Plant Leaves/chemistry , Quercetin/analogs & derivatives , Alloxan , Animals , Antioxidants/chemistry , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/chemistry , Lipid Peroxidation/drug effects , Male , Molecular Structure , Phytotherapy , Plant Extracts/pharmacology , Quercetin/chemistry , Quercetin/pharmacology , Rats , Rats, WistarABSTRACT
Scopoletin (7-hydroxy-6-methoxy coumarin) was isolated from the leaves of Aegle marmelos and evaluated for its potential to regulate hyperthyroidism, lipid peroxidation and hyperglycemia in levo-thyroxine-induced hyperthyroid rats. Scopoletin (1.00 mg/kg, p.o.) administered daily for 7 days to levo-thyroxine-treated animals decreased the levels of serum thyroid hormones and glucose as well as hepatic glucose-6-phosphatase activity, demonstrating its potential to regulate hyperthyroidism and hyperglycemia. Scopoletin also inhibited hepatic lipid peroxidation and increased the activity of antioxidants, superoxide dismutase and catalase. Compared with the standard antithyroid drug, propylthiouracil, scopoletin exhibited a superior therapeutic activity, since unlike propylthiouracil, it also inhibited hepatic lipid peroxidation. These findings indicate that scopoletin has the potential to inhibit thyroid function and hyperglycemia without hepatotoxicity.
Subject(s)
Aegle/chemistry , Antioxidants/pharmacology , Antithyroid Agents/pharmacology , Hypoglycemic Agents/pharmacology , Plant Extracts/pharmacology , Scopoletin/pharmacology , Animals , Antioxidants/administration & dosage , Antithyroid Agents/administration & dosage , Blood Glucose/drug effects , Female , Hyperglycemia/prevention & control , Hyperthyroidism/chemically induced , Hyperthyroidism/drug therapy , Hypoglycemic Agents/administration & dosage , Lipid Peroxidation/drug effects , Plant Extracts/administration & dosage , Plant Extracts/isolation & purification , Plant Leaves/chemistry , Propylthiouracil/administration & dosage , Propylthiouracil/pharmacology , Rats , Rats, Wistar , Scopoletin/administration & dosage , Scopoletin/isolation & purification , Thyroxine/administration & dosage , Thyroxine/pharmacologyABSTRACT
The efficacy of guggulu, the gum resin of Commiphora mukul in regulating hypothyroidism was evaluated in female mice. In addition to estimating serum levels of thyroxine and triiodothyronine, hepatic 5' monodeiodinase, hepatic glucose-6-phospatase and lipid-peroxidation (LPO), the activities of the anti-oxidative enzymes, superoxide dismutase (SOD) and catalase (CAT), were investigated. While 6-n-propyl-2-thiouracil (PTU, 10.00 mg/kg/d for 30 days) induced hypothyroidism in mice, as evidenced by a decrease in thyroid hormone concentration and in hepatic 5'D-I activity, simultaneous administration of guggulu (200 mg/kg/d for 30 days) reversed this effect, indicating its potential to stimulate thyroid function. Although in PTU treated animals a marginal increase in hepatic LPO was observed, when simultaneously treated with guggulu, it was decreased. A parallel increase in the activity of endogenous antioxidants, SOD and CAT, in the latter group indicated the safe and antiperoxidative nature of the drug. These findings suggest the possible use of guggulu in the amelioration of hypothyroidism.
Subject(s)
Phytotherapy , Plant Extracts/pharmacology , Sapindaceae , Thyroid Gland/drug effects , Animals , Female , Hypothyroidism/blood , Hypothyroidism/chemically induced , Hypothyroidism/drug therapy , Lipid Peroxidation/drug effects , Mice , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use , Propylthiouracil , Thyroxine/blood , Thyroxine/drug effects , Triiodothyronine/blood , Triiodothyronine/drug effectsABSTRACT
Extracts of Trigonella foenum-graecum (TFG) seed and Allium sativum (AS) bulb were evaluated for their efficacy to ameliorate l-thyroxine (l-T4) induced hyperglycaemia in rats. Simultaneously, the serum cholesterol concentration, a supporting parameter for thyroid function, was also estimated. Thyroxine treatment in rats (300 microg/kg b. wt./day) increased the levels of both the thyroid hormones, namely thyroxine (T4) and tri-iodothyronine (T3) with a concomitant elevation in serum glucose concentration and a reduction in serum cholesterol level. Administration of TFG (220 mg/kg/day) and AS (500 mg/kg/day) extracts in hyperthyroid animals decreased the serum glucose concentration as well as the serum thyroid hormones. For comparison, propyl thiouracil (PTU), an antithyroid compound, was used as the standard at a daily dose of 10 mg/kg. The reductions in serum glucose and thyroid hormone concentrations in the plant extract treated groups were comparable to that in PTU treated animals. Our findings indicate that TFG seed and AS bulb extracts may prove to be effective in the treatment of thyroxine-induced hyperglycaemia.